Xlife Sciences Ag

xlife sciences ag focuses on the development of life sciences technologies. the company's projects and pipeline include biotech/therapies and technology platforms for antibody therapy, including obesity, acute myeloid leukemia, and acute lymphocytic leukemia; nanovesikel therapy comprising arthritis, ms, and als; painkiller solution; screening technology of antibodies; and modification of antibodies and breakdown of polygeny (genetics). its projects and pipeline also include medical technology and artificial intelligence comprising 3d bioprinting for life; medical technology comprising reprocessing of instruments of surgical robots; medical devices for the early detection of dementia and parkinson's disease; development of bile duct implants; and analysis software (ai) for the diagnosis/evaluation of x-ray and mri images for early detection of prostate cancer. the company is headquartered in zurich, switzerland.